NASDAQ: CLGN
CollPlant Biotechnologies Ltd Earnings & Revenue

CLGN past revenue growth

How has CLGN's revenue growth performed historically?
Company
163.96%
Industry
944.69%
Market
41.92%
CLGN's revenue has grown faster... subscribe to Premium to read more.
Performance
CLGN's revenue has grown faster... subscribe to Premium to read more.
Performance

CLGN earnings and revenue history

Current Revenue
$15.9M
Current Earnings
$1.1M
Current Profit Margin
6.9%

CLGN Return on equity

Current Company
2.9%
Current Industry
8.9%
Current Market
93.9%
CLGN's Return on Equity (2.9%)... subscribe to Premium to read more.
Performance

CLGN Return on assets

Current Company
2.5%
Current Industry
3%
CLGN is generating lower Return... subscribe to Premium to read more.
Performance

CLGN Return on capital employed

Current Company
2.56%
Current Industry
10.9%
CLGN has gotten more efficient... subscribe to Premium to read more.
Performance

CLGN earnings dates

Next earnings date
Mar 24, 2022

CollPlant Biotechnologies Ltd Earnings & Revenue FAQ

What were CLGN's earnings last quarter?

On Invalid Date, CollPlant Biotechnologies Ltd (NASDAQ: CLGN) reported Q3 2021 earnings per share (EPS) of -$0.29, up 390% year over year. Total CollPlant Biotechnologies Ltd earnings for the quarter were -$3.08 million. In the same quarter last year, CollPlant Biotechnologies Ltd's earnings per share (EPS) was $0.10.

What was CLGN's earnings growth in the past year?

As of Q1 2022, CollPlant Biotechnologies Ltd's earnings has grown null year over year. CollPlant Biotechnologies Ltd's earnings in the past year totalled $1.10 million.

What is CLGN's earnings date?

CollPlant Biotechnologies Ltd's earnings date is Invalid Date. Add CLGN to your watchlist to be reminded of CLGN's next earnings announcement.

What was CLGN's revenue last quarter?

On Invalid Date, CollPlant Biotechnologies Ltd (NASDAQ: CLGN) reported Q3 2021 revenue of $140.00 thousand up 96.62% year over year. In the same quarter last year, CollPlant Biotechnologies Ltd's revenue was $4.15 million.

What was CLGN's revenue growth in the past year?

As of Q1 2022, CollPlant Biotechnologies Ltd's revenue has grown 163.96% year over year. This is 780.73 percentage points lower than the US Biotechnology industry revenue growth rate of 944.69%. CollPlant Biotechnologies Ltd's revenue in the past year totalled $15.89 million.
WallStreetZen does not provide financial advice and does not issue recommendations or offers to buy stock or sell any security.

Information is provided 'as-is' and solely for informational purposes and is not advice. WallStreetZen does not bear any responsibility for any losses or damage that may occur as a result of reliance on this data.